March 18, 2014
Wellesley, Mass., March 18, 2014 –BCC Research (www.bccresearch.com) reveals in its new report, CELL-BASED ASSAYS: TECHNOLOGIES AND GLOBAL MARKETS,the global cell-based assays market is expectedto grow to nearly $21.6 billion by 2018, with a five-year compound annual growth rate (CAGR) of 12.4%. The ADME (absorption, degradation, metabolism, excretion) segment is the fastest moving subsegment with a CAGR of 15%
Cell-based assays have emerged as a more relevant alternative to biochemical assays involving the use of purified proteins especially in the field of drug discovery.
Drug discovery for validating drug targets/lead profiling assays is the largest segment in this market in terms of revenue and is expected to grow to $15 billion by 2018. However, ADME and toxicology testing, a critical component to drug development, is the fastest moving segment, growing at a tremendous CAGR of 15%. This segment is expected to reach a global value of nearly $4.6 billion in 2018.
"This market is being driven by new technology innovations and high-throughput screening (HTS) systems," says BCC Research biotechnology analyst Ushu Nagavarapu. "In addition, a need exists to discover the functions of different proteins which can further help in potent drug development. By using bioassays in automated systems, characterization of a large number of drug targets and candidates is possible and the drug-discovery process can be made more efficient."
CELL-BASED ASSAYS: TECHNOLOGIES AND GLOBAL MARKETS provides a detailed overview and thorough analysis of the present and future global market for cell-based techniques. It includes current issues and trends affecting the industry and costs, and factors influencing demand will be discussed. The report covers products in development, new technologies, trends, alliances, and mergers. It offers market data with respect to segments and geography. In addition, this report provides market trends with respect to drivers, restraints, and opportunities.
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.
Cell-based Assays: Technologies and Global Markets( BIO080B )
Publish Date: Apr 2014
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.